Tolerability and Safety of 30, 45, and 60 mg of Sublingual Lobeline. - 1

Status unconfirmed · Phase 1

Conditions studied: Methamphetamine Dependence

In brief

The purpose of this study is to assess safety and pharmacokinetics of sublingual lobeline in healthy normal volunteers.

Key facts

Study ID

NCT00519259

Run by

National Institute on Drug Abuse (NIDA)

People needed

12

Starts

2006-02-01

Last updated by the study team

2017-01-11

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Must be able to provide written informed consent
• Must have a body mass index between 18 and 30
• Have no medical contraindications as determined by medical history, physical exam, ECG, hematology and blood chemistry profile, and urinalysis
• Must have a negative drug test at screening and admission
• If female of child bearing potential, must agree to use birth control

You may not qualify if…

• Please contact the site for more information

Where it is running

• Langley Porter Psychiatric Institute — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.